Minota S, Winfield J B
J Immunol. 1987 Mar 15;138(6):1750-6.
IgG anti-T cell autoantibodies are common in SLE serum, react preferentially with activated lymphocytes, and exert early-phase inhibitory effects on antigen-induced T cell proliferation. Little is known about the target molecules in this system, however, because the low titer and low avidity of the most interesting antibodies limit their utility in conventional immunoprecipitation analyses. Therefore, Western blotting was used to demonstrate binding of IgG in anti-T cell antibody-positive SLE sera to four surface membrane molecules shared by peripheral T cells and HSB-2 cells. Molecules of Mr 90,000 and 55,000 were particularly reactive: each target was stained by IgG anti-lymphocyte antibodies in 11 patient sera (approximately 85%) in the panel. Targets of Mr 37,000 and 105,000 were encountered less frequently (six of 13 and one of 13 patients, respectively). It is unlikely that alloantibodies contributed to the staining patterns observed because reactivity with the four targets was consistently present when cell preparations from multiple unrelated donors were examined. The target molecules were localized to the plasma membrane by whole cell absorption/elution experiments, by the failure of chromatin (DNA/histone) to absorb antibodies to these antigens, and through the use of purified membranes as substrate for Western blotting. With the possible exception of the 105,000 Mr molecule, which is a major target in the IgM anti-T cell antibody system, evidence for the existence of neoantigens as a basis for increased reactivity of SLE IgG with activated T cells was not obtained. The identity of the IgG antibody-reactive molecules with respect to known T cell antigens was not determined, although evidence against the existence of antibodies to Tac (IL 2 receptor) and the transferrin receptor was obtained in monoclonal antibody pre-clearing experiments. Nonetheless, the observation that a limited number of major IgG autoantibody target antigens on activated peripheral T cells are shared by HSB-2 cells, a primitive T cell line expressing few of the differentiation antigens characteristic of mature T cells, should provide a basis for more definitive characterization of antigens in this system in the future.
IgG抗T细胞自身抗体在系统性红斑狼疮(SLE)血清中很常见,它们优先与活化淋巴细胞发生反应,并对抗原诱导的T细胞增殖产生早期抑制作用。然而,关于该系统中的靶分子所知甚少,因为最具研究价值的抗体效价低且亲和力弱,限制了它们在传统免疫沉淀分析中的应用。因此,采用蛋白质印迹法来证明抗T细胞抗体阳性的SLE血清中的IgG与外周血T细胞和HSB - 2细胞共有的四种表面膜分子的结合情况。分子量为90,000和55,000的分子反应尤为明显:在该组11例患者血清(约85%)中,每种靶标均被IgG抗淋巴细胞抗体染色。分子量为37,000和105,000的靶标出现频率较低(分别为13例患者中的6例和1例)。同种抗体不太可能导致观察到的染色模式,因为在检测来自多个无关供体的细胞制剂时,始终能观察到与这四种靶标的反应性。通过全细胞吸收/洗脱实验、染色质(DNA/组蛋白)未能吸收针对这些抗原的抗体以及使用纯化膜作为蛋白质印迹法的底物,将靶分子定位到质膜上。除了分子量为105,000的分子(它是IgM抗T细胞抗体系统中的主要靶标)可能是个例外,未获得新抗原存在的证据来解释SLE IgG与活化T细胞反应性增加的原因。尽管在单克隆抗体预清除实验中获得了反对存在抗Tac(白细胞介素2受体)和转铁蛋白受体抗体的证据,但关于IgG抗体反应性分子与已知T细胞抗原的一致性尚未确定。尽管如此,活化外周血T细胞上有限数量的主要IgG自身抗体靶抗原与HSB - 2细胞(一种几乎不表达成熟T细胞特征性分化抗原的原始T细胞系)共有的这一观察结果,应为未来更明确地鉴定该系统中的抗原提供依据。